Parallax Volatility Advisers, L.P. V Tv Therapeutics Inc. Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	BUY	$0.71 - $4.04 $1,775 - $10,100	2,500 New	2,500 $4,000
Q1 2018 May 15, 2018	SELL	$3.91 - $7.83 $4,433 - $8,879	-1,134 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$3.9 - $7.77 $4,422 - $8,811	1,134	1,134 $7,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.42B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.